Wordt geladen...
High Drug Prices Hurt Everyone
Turing Pharmaceuticals raised the price of Daraprim 5,500%, illustrating how the absence of competition in the sale of low-volume, low-price drugs can lead to price gouging. For patented medicines, society allows supracompetitive pricing to incentivize innovation. However, Gilead’s decision to sell...
Bewaard in:
| Gepubliceerd in: | ACS Med Chem Lett |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Chemical
Society
2016
|
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4904249/ https://ncbi.nlm.nih.gov/pubmed/27326322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.6b00139 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|